ÀÇ·á±â±â ¹Ì±¹ FDA cGMP ½Ç¹«(24³â 2Â÷)
![]() |
100% |
ÀÌ·Ð |
¡á °ú Á¤ ¸í : ÀÇ·á±â±â ¹Ì±¹FDA cGMP ½Ç¹«(24³â 2Â÷)
¡á ±³À°±â°£ : 2024. 11. 19(È) ~ 2024. 11. 20(¼ö)
¡á ±³À°½Ã°£ : 09:30~17:30 (1ÀÏ 7½Ã°£ / ÃÑ 14½Ã°£)
¡á ° »ç : (ÁÖ)Áö¿¥¿¡½ºÄÁ¼³Æà ½Å±Ôö ºÎ´ëÇ¥
¡á ±³À°Àοø : 30¸í
¡á±³À°Æ¯Àü : ½Ä±Ç, ±³Àç ¹«»óÁ¦°ø ¹× ¼ö·áÁõ ¹ß±Þ
* Á¢¼öÀÏ : 2024.10.31 (¸ñ) 10:00~
* ¼ö·á°¡ °¡´ÉÇϽŠºÐ¸¸ ½Åû°¡´ÉÇÕ´Ï´Ù.
1ÀÏÂ÷ (09:30 ~ 17:30)
- ¹Ì±¹ cGMP inspection ÇÁ·Î¼¼½º (1½Ã°£)
- ¹Ì±¹ cGMP inspection ÇÁ·Î¼¼½º(21 CFR Part820 -Management control) (2½Ã°£)
- ¹Ì±¹ cGMP inspection ÇÁ·Î¼¼½º(21 CFR Part820 -Corrective and Preventive Actions (2½Ã°£)
- ¹Ì±¹ cGMP inspection ÇÁ·Î¼¼½º(21 CFR Part820 -Corrective and Process Controls (2½Ã°£)
2ÀÏÂ÷ (09:30 ~ 17:30)
- ¹Ì±¹ cGMP inspection ÇÁ·Î¼¼½º(21 CFR Part820 -Material Controls) (1½Ã°£)
- ¹Ì±¹ cGMP inspection ÇÁ·Î¼¼½º(21 CFR Part820 -Documents/REcords/Change Control) (1½Ã°£)
- ¹Ì±¹ eMDR µî·Ï ÇÁ·Î¼¼½º (1½Ã°£)
- Á¦Ç°À̷±â·Ï(DHR)ÀÛ¼º »ç·Ê¿¬±¸ (1½Ã°£)
- ¹Ì±¹ cGMP ÁöÀû»çÇ× »ç·Ê¿¬±¸ (1½Ã°£)
- 483 Observation ÈļÓÁ¶Ä¡ »ç·Ê¿¬±¸ (2½Ã°£)
* Áᫎ : 12:30~13:30